🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, alleging the companies concealed alleged dangers that the pain reliever created to children's brain development.

The court filing follows thirty days after Donald Trump advocated an unsubstantiated connection between consuming Tylenol - referred to as acetaminophen - while pregnant and autism spectrum disorder in children.

Paxton is suing J&J, which previously sold the drug, the exclusive pain medication recommended for women during pregnancy, and Kenvue, which presently makes it.

In a statement, he claimed they "deceived the public by making money from suffering and marketing drugs regardless of the risks."

The manufacturer asserts there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, stated.

Kenvue stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its official site, the company also stated it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between taking paracetamol and autism."

Associations representing medical professionals and medical practitioners share this view.

ACOG has declared paracetamol - the key substance in Tylenol - is a restricted selection for pregnant women to treat discomfort and fever, which can pose major wellness concerns if not addressed.

"In over twenty years of investigation on the use of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the use of paracetamol in any stage of pregnancy leads to neurological conditions in young ones," the organization stated.

The court filing references latest statements from the former administration in asserting the drug is potentially dangerous.

Last month, the former president raised alarms from public health officials when he instructed expectant mothers to "fight like hell" not to take Tylenol when sick.

The FDA then published an announcement that medical professionals should contemplate reducing the consumption of Tylenol, while also mentioning that "a direct connection" between the medication and autism in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had vowed in April to conduct "comprehensive study program" that would identify the origin of autism in a short period.

But authorities cautioned that identifying a single cause of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of inherited and external influences - would prove challenging.

Autism is a form of permanent neurological difference and impairment that impacts how individuals perceive and interact with the environment, and is identified using medical professional evaluations.

In his court filing, Paxton - a Trump ally who is seeking the Senate - asserts the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

The lawsuit aims to force the companies "remove any marketing or advertising" that claims acetaminophen is secure for expectant mothers.

This legal action mirrors the concerns of a group of parents of children with autism spectrum disorder and ADHD who took legal action against the makers of acetaminophen in two years ago.

Judicial authorities threw out the case, stating investigations from the family's specialists was inconclusive.